Header Logo

Connection

GARABED EKNOYAN to Middle Aged

Back to Details
This is a "connection" page, showing publications GARABED EKNOYAN has written about Middle Aged.
GARABED EKNOYAN
Connection Strength
0.195
Middle Aged
  1. Tubulointerstitial nephritis and cancer chemotherapy: update on a neglected clinical entity. Nephrol Dial Transplant. 2013 Oct; 28(10):2502-9.
    View in: PubMed
    Score: 0.025
  2. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol. 2006 Feb; 17(2):546-55.
    View in: PubMed
    Score: 0.015
  3. Clinical practice guidelines for chronic kidney disease in adults: Part I. Definition, disease stages, evaluation, treatment, and risk factors. Am Fam Physician. 2004 Sep 01; 70(5):869-76.
    View in: PubMed
    Score: 0.013
  4. Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol. 2003 Dec; 14(12):3251-63.
    View in: PubMed
    Score: 0.013
  5. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002 Dec 19; 347(25):2010-9.
    View in: PubMed
    Score: 0.012
  6. Nonsteroidal anti-inflammatory drugs and acute renal failure in the elderly. A risk-benefit assessment. Drugs Aging. 1996 Nov; 9(5):341-51.
    View in: PubMed
    Score: 0.008
  7. Membranous glomerulonephritis associated with inflammatory demyelinating peripheral neuropathies. Am J Kidney Dis. 1996 Feb; 27(2):279-83.
    View in: PubMed
    Score: 0.007
  8. Renal malacoplakia reappraised. Am J Kidney Dis. 1993 Aug; 22(2):243-52.
    View in: PubMed
    Score: 0.006
  9. Evolving spectrum of HIV-associated nephropathy. Nephron Clin Pract. 2012; 121(3-4):c131-5.
    View in: PubMed
    Score: 0.006
  10. Predictors of sudden cardiac death: a competing risk approach in the hemodialysis study. Clin J Am Soc Nephrol. 2012 Jan; 7(1):123-30.
    View in: PubMed
    Score: 0.006
  11. ?-Blockers for prevention of sudden cardiac death in patients on hemodialysis: a propensity score analysis of the HEMO Study. Am J Kidney Dis. 2011 Dec; 58(6):939-45.
    View in: PubMed
    Score: 0.005
  12. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int. 2011 Nov; 80(10):1080-91.
    View in: PubMed
    Score: 0.005
  13. Chronic tubulo-interstitial nephritis: correlation between structural and functional findings. Kidney Int. 1990 Oct; 38(4):736-43.
    View in: PubMed
    Score: 0.005
  14. Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients. Kidney Int. 2010 Apr; 77(7):624-9.
    View in: PubMed
    Score: 0.005
  15. Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study. Am J Kidney Dis. 2008 Sep; 52(3):531-40.
    View in: PubMed
    Score: 0.004
  16. Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2008 Jan; 3(1):69-77.
    View in: PubMed
    Score: 0.004
  17. Inflammation and inverse associations of body mass index and serum creatinine with mortality in hemodialysis patients. J Ren Nutr. 2007 Nov; 17(6):372-80.
    View in: PubMed
    Score: 0.004
  18. Hemodialysis timing, survival, and cardiovascular outcomes in the Hemodialysis (HEMO) Study. Am J Kidney Dis. 2006 Apr; 47(4):614-24.
    View in: PubMed
    Score: 0.004
  19. Renal involvement in patients with thrombotic thrombocytopenic purpura. Am J Nephrol. 1986; 6(2):117-31.
    View in: PubMed
    Score: 0.004
  20. Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. Kidney Int. 2004 Apr; 65(4):1386-94.
    View in: PubMed
    Score: 0.003
  21. Hypertension in older people. Compr Ther. 1983 Dec; 9(12):57-64.
    View in: PubMed
    Score: 0.003
  22. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003 Jan; 41(1):1-12.
    View in: PubMed
    Score: 0.003
  23. Seasonal variations in clinical and laboratory variables among chronic hemodialysis patients. J Am Soc Nephrol. 2002 Sep; 13(9):2345-52.
    View in: PubMed
    Score: 0.003
  24. Phosphate therapy in diabetic ketoacidosis. Arch Intern Med. 1982 Mar; 142(3):517-20.
    View in: PubMed
    Score: 0.003
  25. Renal papillary necrosis: an update. Medicine (Baltimore). 1982 Mar; 61(2):55-73.
    View in: PubMed
    Score: 0.003
  26. Biochemical abnormalities of platelets in renal failure. Evidence for decreased platelet serotonin, adenosine diphosphate and Mg-dependent adenosine triphosphatase. Am J Nephrol. 1981; 1(1):17-23.
    View in: PubMed
    Score: 0.003
  27. Toxic nephropathy during continuous rifampin therapy. South Med J. 1980 Jun; 73(6):791-2.
    View in: PubMed
    Score: 0.003
  28. Acute renal failure associated with indomethacin administration. South Med J. 1980 May; 73(5):587-9.
    View in: PubMed
    Score: 0.002
  29. The effect of age on the character of immune complex disease: a comparison of the incidence and relative size of materials reactive with Clq in sera of patients with glomerulonephritis and cancer. Medicine (Baltimore). 1979 Jan; 58(1):65-79.
    View in: PubMed
    Score: 0.002
  30. Minocycline and doxycycline kinetics in chronic renal failure. Clin Pharmacol Ther. 1978 Aug; 24(2):233-9.
    View in: PubMed
    Score: 0.002
  31. Renal localization of antiglobulins in glomerulonephritis and after renal transplantation. Arthritis Rheum. 1977 May; 20(4):947-61.
    View in: PubMed
    Score: 0.002
  32. Antiglobulins and glomerulonephritis. Classification of patients by the reactivity of their sera and renal tissue with aggregated and native human IgG. J Clin Invest. 1975 Aug; 56(2):427-37.
    View in: PubMed
    Score: 0.002
  33. Renal complications in multiple myeloma: pathophysiology and some aspects of clinical management. J Chronic Dis. 1971 Jul; 24(4):221-7.
    View in: PubMed
    Score: 0.001
  34. Combined ascitic-fluid and furosemide infusion in the management of ascites. N Engl J Med. 1970 Mar 26; 282(13):713-7.
    View in: PubMed
    Score: 0.001
  35. Salutary effects of modest fluid replacement in the treatment of adults with diabetic ketoacidosis. Use in patients without extreme volume deficit. JAMA. 1989 Oct 20; 262(15):2108-13.
    View in: PubMed
    Score: 0.001
  36. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine (Baltimore). 1986 May; 65(3):163-72.
    View in: PubMed
    Score: 0.001
  37. Plasma acid-base patterns in diabetic ketoacidosis. N Engl J Med. 1982 Dec 23; 307(26):1603-10.
    View in: PubMed
    Score: 0.001
  38. Effects of renal failure on leukotaxis. J Med. 1979; 10(4):267-78.
    View in: PubMed
    Score: 0.001
  39. Indomethacin treatment of pericarditis in chronic hemodialysis patients. Arch Intern Med. 1975 Jun; 135(6):807-10.
    View in: PubMed
    Score: 0.000
  40. Mitigation of amphotericin B nephrotoxicity by mannitol. Br Med J. 1975 Mar 08; 1(5957):550-1.
    View in: PubMed
    Score: 0.000
  41. The morphogenesis of glomerular crescents in rapidly progressive glomerulonephritis. Kidney Int. 1974 Jan; 5(1):47-56.
    View in: PubMed
    Score: 0.000
  42. Adult polycystic kidney disease: studies of the defect in urine concentration. Kidney Int. 1972 Aug; 2(2):107-13.
    View in: PubMed
    Score: 0.000
  43. Effects of metolazone on renal function in normal man. J Pharmacol Exp Ther. 1972 Jan; 180(1):6-12.
    View in: PubMed
    Score: 0.000
  44. Peritoneal dialysis in the treatment of renal failure in multiple myeloma. South Med J. 1971 Nov; 64(11):1403-5.
    View in: PubMed
    Score: 0.000
  45. Hereditary nephritis in the Negro. Report of a kindred. Arch Intern Med. 1970 Mar; 125(3):451-8.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.